Cargando…
Two Different Therapeutic Approaches for SARS-CoV-2 in hiPSCs-Derived Lung Organoids
The global health emergency for SARS-CoV-2 (COVID-19) created an urgent need to develop new treatments and therapeutic drugs. In this study, we tested, for the first time on human cells, a new tetravalent neutralizing antibody (15033-7) targeting Spike protein and a synthetic peptide homologous to d...
Autores principales: | Spitalieri, Paola, Centofanti, Federica, Murdocca, Michela, Scioli, Maria Giovanna, Latini, Andrea, Di Cesare, Silvia, Citro, Gennaro, Rossi, Antonio, Orlandi, Augusto, Miersch, Shane, Sidhu, Sachdev S., Pandolfi, Pier Paolo, Botta, Annalisa, Sangiuolo, Federica, Novelli, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997767/ https://www.ncbi.nlm.nih.gov/pubmed/35406799 http://dx.doi.org/10.3390/cells11071235 |
Ejemplares similares
-
Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
por: Novelli, Giuseppe, et al.
Publicado: (2023) -
Effects of Simulated Microgravity on Wild Type and Marfan hiPSCs-Derived Embryoid Bodies
por: Spitalieri, Paola, et al.
Publicado: (2021) -
Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2
por: Spitalieri, Paola, et al.
Publicado: (2018) -
Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling
por: Giovannini, Daniela, et al.
Publicado: (2021) -
Peptide Platform as a Powerful Tool in the Fight against COVID-19
por: Murdocca, Michela, et al.
Publicado: (2021)